Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
15.65 USD   +2.89%
12/02Deciphera Pharmaceuticals Inc. to Present at the JMP Securities Hematology and Oncology Summit
AQ
12/01Deciphera Pharmaceuticals, Inc. to Present at the JMP Securities Hematology and Oncology Summit
BU
11/09Deciphera Pharmaceuticals, Inc. to Participate in Upcoming November 2022 Investor Conferences
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on DECIPHERA PHARMACEUTICALS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) DECIPHERA PHARMACEUTICALS, INC.
Analyst Recommendations on DECIPHERA PHARMACEUTICALS, INC.
09/27Stifel Adjusts Price Target on Deciphera Pharmaceuticals to $18 From $11, Reiterates Hold ..
MT
09/12Piper Sandler Raises Deciphera Pharmaceuticals Price Target to $18 From $13, Maintains Neu..
MT
09/12SVB Securities Adjusts Deciphera Pharmaceuticals' Price Target to $25 from $21, Maintains ..
MT
09/12HC Wainwright Adjusts Deciphera Pharmaceuticals' Price Target to $25 from $20, Reiterates ..
MT
08/29Cowen Starts Deciphera Pharmaceuticals at Outperform With $25 Price Target
MT
08/05HC Wainwright Adjusts Price Target on Deciphera Pharmaceuticals to $20 From $15, Reiterate..
MT
08/05JMP Securities Upgrades Deciphera Pharmaceuticals to Market Outperform From Market Perform..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 15,65 $
Average target price 19,61 $
Spread / Average Target 25,3%
High Price Target 25,00 $
Spread / Highest target 59,7%
Low Price Target 8,00 $
Spread / Lowest Target -48,9%
Consensus detail
Consensus revision (last 18 months)